어플

The FTC has launched an on-site investigation into Ottogi and Guangdong Pharmaceutical on charges of unfair internal transactions

Business / 김지선 / 09/15/2023 03:00 AM
 

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] The Fair Trade Commission has launched an investigation into allegations of unfair support by mid-sized companies such as Ottogi and Kwangdong Pharmaceutical.

According to the industry, the FTC sent investigators to Ottogi and Guangdong Pharmaceutical on the 14th.

The FTC is said to have detected allegations of unfair support from a number of groups as a result of monitoring the status of internal transactions by mid-sized business groups.

Mid-sized business groups have lax external monitoring and a higher proportion of the total family members within the board of directors than large business groups with assets of 5 trillion won or more.

 

 

AlphaBIZ 김지선(stockmk2020@alphabiz.co.kr)

Related articles

Dunamu Sanctioned for Misleading Fee Discount Ads Following FIU Violations
Kakao Mobility Denies Allegations of Abuse of Market Dominance in Taxi App Case
Hyosung Heavy Industries, Others Deny Bid-Rigging Charges in KEPCO Tender Case
Samsung Electronics, SK hynix Slide on Google ‘TurboQuant’ Fears, but Analysts See Demand Intact
NH Investment & Securities Cuts LG Chem Target Price on Petrochemical Weakness, Maintains ‘Buy’
comments >

SNS